Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6242341 | Respiratory Medicine | 2014 | 28 Pages |
Abstract
Mortality is heterogeneous and dependent on entry criteria. Infection rates were high, both with and without immunosuppression, and were higher in severe disease. Consideration should be given to alternative outcomes to mortality in future IPF trials if severe disease is excluded.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
C.P. Atkins, Y.K. Loke, A.M. Wilson,